Last Updated: September 24, 2026

CODRIX Drug Patent Profile

Name: CODRIX Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Codrix, and what generic alternatives are available?

Codrix is a drug marketed by Watson Labs Florida and is included in three NDAs.

The generic ingredient in CODRIX is acetaminophen; codeine phosphate. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Codrix

A generic version of CODRIX was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31^st, 1969.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CODRIX?
What are the global sales for CODRIX?
What is Average Wholesale Price for CODRIX?

Summary for CODRIX

US Patents:	0
Applicants:	1
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	5
Patent Applications:	69
DailyMed Link:	CODRIX at DailyMed

Drug patent expirations by year for CODRIX

US Patents and Regulatory Information for CODRIX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs Florida	CODRIX	acetaminophen; codeine phosphate	TABLET;ORAL	040447-001	Feb 26, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs Florida	CODRIX	acetaminophen; codeine phosphate	TABLET;ORAL	040441-001	Mar 27, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs Florida	CODRIX	acetaminophen; codeine phosphate	TABLET;ORAL	040488-001	Mar 28, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.